Craft

Medartis Holding

Stock Price

CHF67.6

2024-08-16

Market Capitalization

CHF918.1 M

2024-08-16

Revenue

CHF212 M

FY, 2023

Medartis Holding Summary

Company Summary

Overview
Medartis Holding is a medical device company that develops, manufactures, and sells implant solutions for internal surgical fixation. The Company's products include plates and screws, and instruments that are used to treat various fractures, osteotomies, degenerative diseases, and orthognathic disorders. It offers implants in cranial and maxillofacial fractures of the skull, and extremities for hand, wrist, elbow, and foot. 
Type
Public
Status
Active
Founded
1997
HQ
Basel, CH | view all locations
Website
http://www.medartis.com/home/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Dominique Leutwyler

    Dominique Leutwyler, CFO

    • Christoph Brönnimann, Chief Executive Officer

      • Willi Miesch
      • Axel Maltzen

        Axel Maltzen, Chief Production Officer

        LocationsView all

        11 locations detected

        • Basel, Basel-Stadt HQ

          Switzerland

          60E Hochbergerstrasse

        • Exton, PA

          United States

          224 Valley Creek Blvd #100

        • Bowen Hills, QLD

          Australia

          64 Brookes St

        • Lustenau, Vorarlberg

          Austria

          Rheinstraße 26

        • SP

          Brazil

          R. Sena Madureira, 796 - Vila Clementino

        • Vaulx-Milieu, Auvergne-Rhône-Alpes

          France

          Zac L'Îlot Des Sables, 720 Rue le Chatelier

        and 5 others

        Medartis Holding Financials

        Summary Financials

        Revenue (FY, 2023)
        CHF212.0M
        Gross profit (FY, 2023)
        CHF172.6M
        Net income (FY, 2023)
        CHF619.0K
        Cash (FY, 2023)
        CHF25.2M
        EBIT (FY, 2023)
        CHF9.1M
        Enterprise value
        $919.8M

        Footer menu